B-TYPE NATRIURETIC PEPTIDE DURING TREATMENT WITH SACUBITRIL/VALSARTAN: THE PARADIGM-HF TRIAL

被引：7
|
作者：
Vaduganathan, Muthiah [1 ]
Myhre, Peder [1 ]
Claggett, Brian [1 ]
Packer, Milton [1 ]
Desai, Akshay S. [1 ]
Rouleau, Jean L. [1 ]
Zile, Michael R. [1 ]
Swedberg, Karl [1 ]
Lefkowitz, Martin [1 ]
Shi, Victor [1 ]
McMurray, John J. V. [1 ]
Solomon, Scott D. [1 ]
机构：
[1] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2019年 / 73卷 / 09期
关键词：
D O I：
10.1016/S0735-1097(19)33679-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
915-08
引用
收藏
页码：3073 / 3073
页数：1
相关论文
共 50 条
  • [1] B-Type Natriuretic Peptide During Treatment With Sacubitril/Valsartan The PARADIGM-HF Trial
    Myhre, Peder Langeland
    Vaduganathan, Muthiah
    Claggett, Brian
    Packer, Milton
    Desai, Akshay S.
    Rouleau, Jean L.
    Zile, Michael R.
    Swedberg, Karl
    Lefkowitz, Martin
    Shi, Victor
    McMurray, John J. V.
    Solomon, Scott D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (11) : 1264 - 1272
  • [2] Sacubitril/valsartan in PARADIGM-HF
    Flores, Dayana
    Sabti, Zaid
    Kozhuharov, Nikola
    Mueller, Christian
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 495 - 495
  • [3] Sacubitril/valsartan in PARADIGM-HF Reply
    Seferovic, Jelena P.
    Claggett, Brian
    Solomon, Scott D.
    LANCET DIABETES & ENDOCRINOLOGY, 2017, 5 (07): : 496 - 496
  • [4] Urinary cGMP (Cyclic Guanosine Monophosphate)/BNP (B-Type Natriuretic Peptide) Ratio, Sacubitril/Valsartan, and Outcomes in Heart Failure With Reduced Ejection Fraction: An Analysis of the PARADIGM-HF Trial
    Butt, Jawad H.
    Ibrahim, Wasyla
    Dewan, Pooja
    Desai, Akshay S.
    Kober, Lars
    Prescott, Margaret F.
    Lefkowitz, Martin P.
    Rouleau, Jean L.
    Solomon, Scott D.
    Zile, Michael R.
    Packer, Milton
    Jhund, Pardeep S.
    McMurray, John J. V.
    CIRCULATION-HEART FAILURE, 2023, 16 (03) : 247 - 258
  • [5] Sacubitril/valsartan and B-type natriuretic peptide value: recalculating route
    Abellas-Sequeiros, Maria
    del Prado Diaz, Susana
    Manuel del Rey, Jose
    Luis Alonso-Salinas, Gonzalo
    Luis Zamorano, Jose
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (01) : 162 - +
  • [6] Safety of sacubitril/valsartan in patients receiving statins in the PARADIGM-HF trial
    Streefkerk, H.
    Anand, D.
    Zhou, W.
    Balas, B.
    Schwende, H.
    Shi, V.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 411 - 412
  • [7] Efficacy of Sacubitril/Valsartan Relative to a Prior Decompensation The PARADIGM-HF Trial
    Solomon, Scott D.
    Claggett, Brian
    Packer, Milton
    Desai, Akshay
    Zile, Michael R.
    Swedberg, Karl
    Rouleau, Jean
    Shi, Victor
    Lefkowitz, Martin
    McMurray, John J. V.
    JACC-HEART FAILURE, 2016, 4 (10) : 816 - 822
  • [8] The effects of sacubitril/valsartan on coronary outcomes in PARADIGM-HF
    Mogensen, Ulrik M.
    Kober, Lars
    Kristensen, Soren L.
    Jhund, Pardeep S.
    Gong, Jianjian
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Shi, Victor C.
    Swedberg, Karl
    Zile, Michael R.
    Solomon, Scott D.
    Packer, Milton
    McMurray, John J. V.
    AMERICAN HEART JOURNAL, 2017, 188 : 35 - 41
  • [9] Prevalent and Incident Anemia in PARADIGM-HF and the Effect of Sacubitril/Valsartan
    Curtain, James P.
    Adamson, Carly
    Docherty, Kieran F.
    Jhund, Pardeep S.
    Desai, Akshay S.
    Lefkowitz, Martin P.
    Rizkala, Adel R.
    Rouleau, Jean L.
    Swedberg, Karl
    Zile, Michael R.
    Solomon, Scott D.
    Packer, Milton
    Mcmurray, John J. V.
    JACC-HEART FAILURE, 2023, 11 (07) : 749 - 759
  • [10] Prevalent and incident anaemia in PARADIGM-HF and effect of sacubitril/valsartan
    Curtain, J.
    Adamson, C.
    Jhund, P. S.
    Desai, A. S.
    Lefkowitz, M. P.
    Rizkala, A. R.
    Rouleau, J. L.
    Swedberg, K.
    Zile, M. R.
    Solomon, S. D.
    Packer, M.
    McMurray, J. J. V.
    EUROPEAN HEART JOURNAL, 2022, 43 : 976 - 976
12345